Serve as the medical lead for LC-FAOD, MPS VII, and MPS IIIA, accountable for regional pull-through of global medical strategy and execution of US tactical plans.
Lead the UX111 US medical launch, partnering with Field Medical and Gene Therapy Treatment Teams to develop a robust launch plan.
Build and maintain strong relationships with KOLs, integrate insights into strategic planning, and lead collaborations on advisory boards and payer education.
Lead a team of UltraCare Liaisons to drive launch and commercialization of the neurology portfolio in the Great Lakes region.
Develop and execute regional business strategies, coaching field teams to achieve performance objectives and compliance.
Collaborate cross-functionally with Medical Affairs, Market Access, and other stakeholders to optimize patient access and business outcomes.
Ultragenyx is a biopharmaceutical company dedicated to developing life-changing treatments for rare diseases. They foster a supportive and inclusive culture focused on growth and learning.
Develop and execute the Japan Medical Plan in close collaboration with the Executive Medical Director and global teams.
Partner with the local Field Medical team to enhance KOL engagement, identify speakers, and support clinical trial enrollment.
Provide balanced scientific and medical information through presentations, advisory boards, and feedback to internal stakeholders.
Ultragenyx is a biopharmaceutical company dedicated to developing treatments for rare diseases by challenging the status quo and creating a new model for patient care. The company fosters a supportive and inclusive culture focused on learning and growth, with a global team committed to making a meaningful impact.
Lead the development and execution of medical affairs strategy for gene therapy programs across sickle cell disease and thalassemia.
Build and maintain external relationships with key opinion leaders and healthcare providers to provide scientific and clinical information.
Provide medical leadership to cross-functional teams and contribute to medical education and communications.
Genetix Biotherapeutics is a biotechnology company pursuing curative gene therapies for severe genetic diseases. It is the only company with three FDA approved gene therapy products and fosters a collaborative, diverse culture focused on innovation and patient care.
Serve as a knowledgeable healthcare provider and patient advocate, educating on LC-FAOD therapy adherence.
Coordinate with HCPs and care teams to implement care plans that mitigate side effects and improve outcomes.
Engage with patients and caregivers through personalized counseling to address barriers to effective therapy.
Ultragenyx is a biopharmaceutical company focused on rare disease medicine, challenging the status quo to create life-changing treatments for patients. The company fosters a supportive and inclusive culture of learning and growth, aiming to be an organization employees are proud of.